期刊
NATURE BIOTECHNOLOGY
卷 20, 期 2, 页码 143-148出版社
NATURE AMERICA INC
DOI: 10.1038/nbt0202-143
关键词
-
资金
- NCI NIH HHS [CA-16520] Funding Source: Medline
- NIDDK NIH HHS [DK-19525, DK07748] Funding Source: Medline
The ex vivo priming and expansion of human cytotoxic T lymphocytes (CTLs) has potential for use in immunotherapy applications for cancer and infectious diseases. To overcome the difficulty in obtaining sufficient numbers of CTLs, we have developed artificial antigen-presenting cells (aAPCs) expressing ligands for the T-cell receptor (TCR) and the CD28 and 4-1BB co-stimulatory surface molecules. These aAPCs reproducibly activate and rapidly expand polyclonal or antigen-specific CD8(+) T cells. The starting repertoire of CD8(+) T cells was preserved during culture. Furthermore, apoptosis of cultured CD8(+) T cells was diminished by this approach. This approach may have important therapeutic implications for adoptive immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据